Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.
Insulin Biosimilars - More focus than ever on Glucose Clamp studies
We record all of our free online seminars, so that you have the possibility to watch them on-demand at your convenience. Watch here our on-demand online seminar titled: "Insulin Biosimilars - More focus than ever on Glucose Clamp studies". Profil's Co-Founder and Lead Scientist Dr. Tim Heise gives you valuable information regarding the development of biosimilar insulins and explains what authorities are looking for. Watch here
CTR 536/2014: Where do we come from and where do we go?
Although the "Clinical Trial Regulation" came into force in May 2014, it took a while until the message "Portal ready to use" was received. In January 31st the "Clinical Trials Information System" (CTIS) became the single entry point for submitting clinical trials in the EU. In this two part blog post series Dr. Grit Andersen and Tatiana Dicenzo summarize the changes and chances which come with the new system. Read more
A co-formulation of pramlintide and insulin A21G (ADO09)
The co-formulation of pramlintide and insulin A21G (ADO09) requires additional injections, but can have benefits regarding postprandial glucose and short term control of mean glucose. Read our latest publication about recent study results of this co-formulation compared to insulin aspart in adult patients with type 1 diabetes mellitus. Read more
Meet us at upcoming conferences
Are you interested in knowing more about Profil? We attend all major conferences focused on diabetes, so if you are planning to go to any upcoming conference, we would love to schedule a meeting and tell you more about our expertise! Upcoming events in 2022:
KoreaPharm, April 18 - 21, 2023, Ilsanseo-gu, South Korea
Asia Bio, April 26 - 27 2023, Singapore
OCT Europe, May 03 - 04 2023, Barcelona, Spain
Bio International Convention, June 05 - 08 2023, Boston, MA, USA
ADA 83rd Scientific Sessions, June 23 - 26 2023, San Diego, CA, USA